Noticias de GH_US

Mercado

Noticias del mercado

Últimas noticias sobre GH_US — 414 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: GH_US ✕ 414 resultados
16/10/2026 GH_US — Yahoo Finance
Guardant Health, Inc. (GH) Options Chain
16/10/2026 GH_US — Yahoo Finance
Guardant Health, Inc. (GH) Options Chain
16/10/2026 GH_US — Yahoo Finance ES ← EN
Cadena de opciones de Guardant Health, Inc. (GH)

Guardant Health, Inc. (GH) Options Chain

15/10/2026 GH_US — Investing.com
Guardant Health director Alex M. Azar II sells $11,032 in stock
15/10/2026 GH_US — Investing.com
Guardant Health director Alex M. Azar II sells $11,032 in stock
15/10/2026 GH_US — Investing.com
Form 4 Guardant Health Inc: Alex M. Azar II (Director) For: 14 October
15/10/2026 GH_US — Investing.com
Guardant Health director Alex M. Azar II sells $11,032 in stock
15/10/2026 GH_US — Investing.com ES ← EN
El director de Guardant Health, Alex M. Azar II, vende acciones por valor de 11.032 dólares

Guardant Health director Alex M. Azar II sells $11,032 in stock

15/10/2026 GH_US — Investing.com
Form 4 Guardant Health Inc: Alex M. Azar II (Director) For: 14 October
15/10/2026 GH_US — Investing.com
Form 4 Guardant Health Inc: Alex M. Azar II (Director) For: 14 October
15/10/2026 GH_US — CNN
symbol__ Stock Quote Price and Forecast

Vea los precios de cotización de acciones de Guardant Health, Inc. GH, información financiera, pronósticos en tiempo real y noticias de la compañía de CNN.

15/10/2026 GH_US — Bloomberg Law News
Guardant Again Fails to Ax Patent Underlying $245 Million Loss
15/10/2026 GH_US — Bloomberg Law News
Guardant didn’t demonstrate two prior patent applications and two research papers rendered the patent obvious, according to the decision
15/10/2026 GH_US — Seeking Alpha
Guardant Health loses challenge regarding DNA sequencing patent

PTAB rejects Guardant Health’s challenge to TwinStrand/University of Washington DNA sequencing patent. Read more here.

15/10/2026 GH_US — Investing.com
PTAB upholds University of Washington patent against Guardant challenge By Investing.com
15/10/2026 GH_US — Investing.com
PTAB upholds University of Washington patent against Guardant challenge
15/10/2026 GH_US — Stock Titan
A colon cancer blood test had 99% screening follow-through at two rural clinics

A lifetime model projected 12 colorectal cancer deaths averted per 1,000 simulated people with blood screening, versus 6 and 9, respectively, with stool tests.

14/10/2026 GH_US — Stock Titan
A director proposes selling 69 Guardant Health (GH) shares valued at $11,032.
14/10/2026 GH_US — Moomoo
Is Now An Opportune Moment To Examine Guardant Health, Inc. (NASDAQ:GH)?
14/10/2026 GH_US — Investing.com
Form 4 Guardant Health Inc: Alex M. Azar II (Director) For: 12 October

Página 2 de 21